Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access

Abstract

Community pharmacies are well positioned to participate in harm-minimisation services to reduce harms caused by both licit and illicit substances. Considering developments in pharmacist practices and the introduction of new professional pharmacy services, we identified a need to explore the contemporary role of community pharmacy in harm minimisation. Semi-structured interviews were undertaken to explore the opinions of stakeholders, pharmacy staff, and clients about the role of community pharmacy in harm minimisation, including provision of current services, experiences, and expectations. Participants (n = 28) included 5 stakeholders, 9 consumers, and 14 staff members from seven community pharmacies. Three over-arching themes were identified across the three participants groups: (i) scope and provision, (ii) complexity, and (iii) importance of person-centred advice and support in relation to community pharmacy harm minimisation services. Community pharmacies are valuable healthcare destinations for delivery of harm minimisation services, with scope for service expansion. Further education, support, and remuneration are needed, as well as linkage to other sector providers, in order to ensure that pharmacists and pharmacy staff are well equipped to provide a range of harm minimisation services.

Management of Medicines Wastage, Returned Medicines and Safe Disposal in Malaysian Community Pharmacies: A Qualitative Study

“…Studies have suggested that minimizing medical wastage improves the quality of the healthcare system through better utilization of healthcare resources, allowing healthcare professionals to emphasize patient care ( 26 – 28 ).…”

Health worker perceptions of the impact of COVID‐19 on harm reduction services for people who inject drugs

“…Harm reduction sites have the potential to be critical health and social care access points for people who would otherwise may have very little to do with mainstream health services, allowing staff opportunities to engage with those harder to reach and provide opportunistic counselling and healthcare (McMillan et al., 2021 ; Williams et al., 2019 ). Staff concern about the closure of socialising spaces highlights that this is a key aspect of many harm reduction services as this client group may have limited opportunities to socialise in a welcoming environment.…”

Exploring the role of community pharmacies as a harm reduction environment for anabolic–androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists

“…Community pharmacies are essential healthcare destinations that serve as an optimal resource for addressing non-urgent inquiries, such as safe injecting practices, management of adverse drug reactions, and medication provision, thus reducing the burden on general practitioners (GPs) [ 1 , 2 ]. Pharmacists also have a role in addressing social determinants of health and promoting health equity, including the support of primary prevention strategies such as harm reduction interventions [ 3 ], for example through needle and syringe programs (NSPs) [ 4 , 5 ]. In addition to offering advice and facilitating HIV/Hepatitis testing, pharmacists serve as a vital referral mechanism to various social, medical, and treatment services [ 6 ].…”